ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Orthopaedic Surgery

Top Orthopaedic Surgery Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BEN GARRIDO MD

Orthopaedic Surgery

3,065

$145K

156
117 are 65+

29%
patients receiving schedule two controlled substances

Avg: 24%

29%
patients receiving schedule three controlled substances

Avg: 37%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 10%

$47
Average prescription price

Avg: $35

CLIFFORD WHEELESS M.D.

Orthopaedic Surgery

2,496

$143K

532
301 are 65+

28%
patients receiving schedule two controlled substances

Avg: 24%

36%
patients receiving schedule three controlled substances

Avg: 37%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 10%

$57
Average prescription price

Avg: $35

JOHN KEELING M.D.

Orthopaedic Surgery

2,342

$44.4K

245
142 are 65+

18%
patients receiving schedule two controlled substances

Avg: 24%

57%
patients receiving schedule three controlled substances

Avg: 37%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

4%
prescriptions for brand name drugs

Avg: 10%

$19
Average prescription price

Avg: $35

SURENDRAPAL MAC MD

Orthopaedic Surgery

1,933

$76.4K

221
125 are 65+

15%
patients receiving schedule two controlled substances

Avg: 24%

33%
patients receiving schedule three controlled substances

Avg: 37%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 10%

$40
Average prescription price

Avg: $35

GEORGE VEASY MD

Orthopaedic Surgery

1,892

$64.5K

356
153 are 65+

4%
patients receiving schedule two controlled substances

Avg: 24%

42%
patients receiving schedule three controlled substances

Avg: 37%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 10%

$34
Average prescription price

Avg: $35

CRAIG BENNETT M.D.

Orthopaedic Surgery

1,846

$70.4K

378
304 are 65+

10%
patients receiving schedule two controlled substances

Avg: 24%

39%
patients receiving schedule three controlled substances

Avg: 37%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 10%

$38
Average prescription price

Avg: $35

DOUGLAS FREELS M.D.

Orthopaedic Surgery

1,780

$25.7K

306
180 are 65+

22%
patients receiving schedule two controlled substances

Avg: 24%

58%
patients receiving schedule three controlled substances

Avg: 37%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

4%
prescriptions for brand name drugs

Avg: 10%

$14
Average prescription price

Avg: $35

ARTHUR CARTER MD

Orthopaedic Surgery

1,729

$46.9K

174
112 are 65+

28%
patients receiving schedule two controlled substances

Avg: 24%

55%
patients receiving schedule three controlled substances

Avg: 37%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 10%

$27
Average prescription price

Avg: $35

MARIANNE PAUL

Orthopaedic Surgery

1,664

$246K

101
14 are 65+

68%
patients receiving schedule two controlled substances

Avg: 24%

13%
patients receiving schedule three controlled substances

Avg: 37%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 10%

$148
Average prescription price

Avg: $35

MARK BRENNER M.D.

Orthopaedic Surgery

1,660

$26.4K

551
364 are 65+

18%
patients receiving schedule two controlled substances

Avg: 24%

57%
patients receiving schedule three controlled substances

Avg: 37%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

6%
prescriptions for brand name drugs

Avg: 10%

$16
Average prescription price

Avg: $35

FRANK ALUISIO MD

Orthopaedic Surgery

1,644

$49K

395
342 are 65+

42%
patients receiving schedule two controlled substances

Avg: 24%

29%
patients receiving schedule three controlled substances

Avg: 37%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 10%

$30
Average prescription price

Avg: $35

JAMES CALIFF M.D.

Orthopaedic Surgery

1,607

$141K

321
206 are 65+

37%
patients receiving schedule two controlled substances

Avg: 24%

37%
patients receiving schedule three controlled substances

Avg: 37%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 10%

$88
Average prescription price

Avg: $35

STANLEY HARRISON M.D.

Orthopaedic Surgery

1,527

$27.8K

253
151 are 65+

7%
patients receiving schedule two controlled substances

Avg: 24%

62%
patients receiving schedule three controlled substances

Avg: 37%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

6%
prescriptions for brand name drugs

Avg: 10%

$18
Average prescription price

Avg: $35

RALPH CARTER MD

Orthopaedic Surgery

1,480

$105K

267
149 are 65+

19%
patients receiving schedule two controlled substances

Avg: 24%

63%
patients receiving schedule three controlled substances

Avg: 37%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 10%

$71
Average prescription price

Avg: $35

RALPH LIEBELT M.D.

Orthopaedic Surgery

1,472

$81K

293
170 are 65+

44%
patients receiving schedule two controlled substances

Avg: 24%

29%
patients receiving schedule three controlled substances

Avg: 37%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 10%

$55
Average prescription price

Avg: $35

HOWARD HOMESLEY MD

Orthopaedic Surgery

1,440

$72.7K

313
195 are 65+

29%
patients receiving schedule two controlled substances

Avg: 24%

52%
patients receiving schedule three controlled substances

Avg: 37%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 10%

$50
Average prescription price

Avg: $35

SETH JAFFE DO

Orthopaedic Surgery

1,425

$26.7K

279
114 are 65+

54%
patients receiving schedule two controlled substances

Avg: 24%

23%
patients receiving schedule three controlled substances

Avg: 37%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

3%
prescriptions for brand name drugs

Avg: 10%

$19
Average prescription price

Avg: $35

IAN ARCHIBALD MD

Orthopaedic Surgery

1,317

$64.3K

281
182 are 65+

19%
patients receiving schedule two controlled substances

Avg: 24%

50%
patients receiving schedule three controlled substances

Avg: 37%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 10%

$49
Average prescription price

Avg: $35

BRUCE DARDEN MD

Orthopaedic Surgery

1,243

$31.3K

280
207 are 65+

27%
patients receiving schedule two controlled substances

Avg: 24%

47%
patients receiving schedule three controlled substances

Avg: 37%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

4%
prescriptions for brand name drugs

Avg: 10%

$25
Average prescription price

Avg: $35

WERNER BROOKS M.D.

Orthopaedic Surgery

1,210

$21.2K

301
220 are 65+

43%
patients receiving schedule two controlled substances

Avg: 24%

34%
patients receiving schedule three controlled substances

Avg: 37%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

6%
prescriptions for brand name drugs

Avg: 10%

$18
Average prescription price

Avg: $35

SAMI OWEIDA MD

Orthopaedic Surgery

1,204

$30.6K

244
187 are 65+

9%
patients receiving schedule two controlled substances

Avg: 24%

52%
patients receiving schedule three controlled substances

Avg: 37%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

7%
prescriptions for brand name drugs

Avg: 10%

$25
Average prescription price

Avg: $35

JOHN MOORE M.D.

Orthopaedic Surgery

1,202

$21K

532
410 are 65+

14%
patients receiving schedule two controlled substances

Avg: 24%

18%
patients receiving schedule three controlled substances

Avg: 37%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

4%
prescriptions for brand name drugs

Avg: 10%

$17
Average prescription price

Avg: $35

LAWRENCE LARABEE MD

Orthopaedic Surgery

1,186

$43.4K

343
206 are 65+

33%
patients receiving schedule two controlled substances

Avg: 24%

54%
patients receiving schedule three controlled substances

Avg: 37%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 10%

$37
Average prescription price

Avg: $35

ROBERT HUMBLE MD

Orthopaedic Surgery

1,184

$48.9K

216
120 are 65+

44%
patients receiving schedule two controlled substances

Avg: 24%

45%
patients receiving schedule three controlled substances

Avg: 37%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

7%
prescriptions for brand name drugs

Avg: 10%

$41
Average prescription price

Avg: $35

RICHARD HOLM MD

Orthopaedic Surgery

1,176

$36.2K

344
240 are 65+

10%
patients receiving schedule two controlled substances

Avg: 24%

43%
patients receiving schedule three controlled substances

Avg: 37%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 10%

$31
Average prescription price

Avg: $35

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank